Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending October 31, 2022 was 256.14% (a -34.98% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -72.63%
- Annual Research and Development (R&D) Expenses Growth for 2022 was 296.93% (a -1879.09% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was -16.69% (a -51.89% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was -34.69% (a -166.78% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending October 31, 2022 was 404.17% (a -21.62% decrease compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth increased by 70.35% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 31 Oct '22 | 31 Jul '22 | 30 Apr '22 | 31 Jan '22 |
|---|---|---|---|
| 404.17% | 515.64% | 352.29% | 237.26% |
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of BRIACELL THERAP
Most recent Research and Development (R&D) Expenses Growthof BCTX including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of BRIACELL THERAP
BRIACELL THERAP Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 256.14% | 393.94% | 525.77% | 935.91% | 296.93% |
| 2021 | 495.4% | 6.61% | 97.97% | -82.08% | -16.69% |
| 2020 | -80.18% | -39.05% | -75.26% | -24.92% | -34.69% |
| 2019 | -1.3% | -6.41% | 58.21% | 106.46% | 51.95% |
| 2018 | 103.69% | 45.53% | -9.68% | 269.85% | 52.54% |
| 2017 | 85.57% | 67.18% | 2768.32% | 5.08% | 124.42% |
| 2016 | 35.21% | 66.31% | -8.18% | 163.57% | 120.47% |
| 2015 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2014 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2013 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2012 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology